AMG-386 (trebananib), a peptide-Fc fusion protein, was observed to diminish tumor angiogenesis and further retard tumor progression via interfering with the binding of Ang-1 and Ang-2 to the Tie-2 receptor (150). The gene discussed is ANGPT1; the disease is neoplasm.